01/28/2026
Dr. Ben Lockshin of U.S. Dermatology Partners Rockville, MD and Director of Clinical Trials participated on an engaging virtual panel with the Dermatology Times. This insightful discussion covered atopic dermatosis treatment—specifically focusing on the evolution of topical PDE4 inhibitors.
Through real-world case presentations, this series highlighted the importance of individualized care, ongoing patient education, and the ways targeted therapies can improve both physical and mental well-being for adult and pediatric patients and their families.
Check out the insights, findings, and perspectives on how these innovations are enhancing quality of life for patients.
https://bit.ly/4t1KGok